The oncology team at CHOC is overcoming common challenges — and delivering survival outcomes better than the national average.
Recent Advancements Shape the Future of Sarcoma Care
At CHOC, collaborative research, experimental treatment protocols & surgical advancements are setting the stage to change sarcoma treatment.
Multidisciplinary Approach to Pediatric Cancer Treatment Benefits an Underserved Young Adult Population
A model for other programs, CHOC’s adolescent and young adult program offers comprehensive oncology care to an underserved population.
Study determines that Pain Buddy app may aid in reduction of pain severity
A new app may help reduce pain severity in children during cancer treatment, a recently published pilot study finds.
Clinical trials continue the advancement of pediatric oncology treatment
CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
